Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5

ABSTRACT It has recently emerged that HIV-1 Nef counteracts the antiviral host proteins SERINC3 and SERINC5. In particular, SERINC5 inhibits the infectivity of progeny virions when incorporated. SERINC3 and SERINC5 are also counteracted by the unrelated murine leukemia virus glycosylated Gag (glycoG...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuanfei Wu, Balaji Olety, Eric R. Weiss, Elena Popova, Hikaru Yamanaka, Heinrich Göttlinger
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
Nef
Acceso en línea:https://doaj.org/article/4570759b8a0d412fab429d4bc1dbaa0d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4570759b8a0d412fab429d4bc1dbaa0d
record_format dspace
spelling oai:doaj.org-article:4570759b8a0d412fab429d4bc1dbaa0d2021-11-15T15:55:23ZPotent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC510.1128/mBio.01071-192150-7511https://doaj.org/article/4570759b8a0d412fab429d4bc1dbaa0d2019-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01071-19https://doaj.org/toc/2150-7511ABSTRACT It has recently emerged that HIV-1 Nef counteracts the antiviral host proteins SERINC3 and SERINC5. In particular, SERINC5 inhibits the infectivity of progeny virions when incorporated. SERINC3 and SERINC5 are also counteracted by the unrelated murine leukemia virus glycosylated Gag (glycoGag) protein, which possesses a potent Nef-like activity on HIV-1 infectivity. We now report that a minimal glycoGag termed glycoMA can fully substitute for Nef in promoting HIV-1 replication in Jurkat T lymphoid cells, indicating that Nef enhances replication in these cells mainly by counteracting SERINCs. In contrast, the SERINC antagonist glycoMA was unable to substitute for Nef in MOLT-3 T lymphoid cells, in which HIV-1 replication was highly dependent on Nef, and remained so even in the absence of SERINC3 and SERINC5. As in MOLT-3 cells, glycoMA was unable to substitute for Nef in stimulating HIV-1 replication in primary human cells. Although the ability of Nef mutants to promote HIV-1 replication in MOLT-3 cells correlated with the ability to engage endocytic machinery and to downregulate CD4, Nef nevertheless rescued virus replication under conditions where CD4 downregulation did not occur. Taken together, our observations raise the possibility that Nef triggers the endocytosis of a novel antiviral factor that is active against both laboratory-adapted and primary HIV-1 strains. IMPORTANCE The Nef protein of HIV-1 and the unrelated glycoGag protein of a murine leukemia virus similarly prevent the uptake of antiviral host proteins called SERINC3 and SERINC5 into HIV-1 particles, which enhances their infectiousness. We now show that although both SERINC antagonists can in principle similarly enhance HIV-1 replication, glycoGag is unable to substitute for Nef in primary human cells and in a T cell line called MOLT-3. In MOLT-3 cells, Nef remained crucial for HIV-1 replication even in the absence of SERINC3 and SERINC5. The pronounced effect of Nef on HIV-1 spreading in MOLT-3 cells correlated with the ability of Nef to engage cellular endocytic machinery and to downregulate the HIV-1 receptor CD4 but nevertheless persisted in the absence of CD4 downregulation. Collectively, our results provide evidence for a potent novel restriction activity that affects even relatively SERINC-resistant HIV-1 isolates and is counteracted by Nef.Yuanfei WuBalaji OletyEric R. WeissElena PopovaHikaru YamanakaHeinrich GöttlingerAmerican Society for MicrobiologyarticleNefSERINC5human immunodeficiency virusinfectivityvirus replicationMicrobiologyQR1-502ENmBio, Vol 10, Iss 3 (2019)
institution DOAJ
collection DOAJ
language EN
topic Nef
SERINC5
human immunodeficiency virus
infectivity
virus replication
Microbiology
QR1-502
spellingShingle Nef
SERINC5
human immunodeficiency virus
infectivity
virus replication
Microbiology
QR1-502
Yuanfei Wu
Balaji Olety
Eric R. Weiss
Elena Popova
Hikaru Yamanaka
Heinrich Göttlinger
Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5
description ABSTRACT It has recently emerged that HIV-1 Nef counteracts the antiviral host proteins SERINC3 and SERINC5. In particular, SERINC5 inhibits the infectivity of progeny virions when incorporated. SERINC3 and SERINC5 are also counteracted by the unrelated murine leukemia virus glycosylated Gag (glycoGag) protein, which possesses a potent Nef-like activity on HIV-1 infectivity. We now report that a minimal glycoGag termed glycoMA can fully substitute for Nef in promoting HIV-1 replication in Jurkat T lymphoid cells, indicating that Nef enhances replication in these cells mainly by counteracting SERINCs. In contrast, the SERINC antagonist glycoMA was unable to substitute for Nef in MOLT-3 T lymphoid cells, in which HIV-1 replication was highly dependent on Nef, and remained so even in the absence of SERINC3 and SERINC5. As in MOLT-3 cells, glycoMA was unable to substitute for Nef in stimulating HIV-1 replication in primary human cells. Although the ability of Nef mutants to promote HIV-1 replication in MOLT-3 cells correlated with the ability to engage endocytic machinery and to downregulate CD4, Nef nevertheless rescued virus replication under conditions where CD4 downregulation did not occur. Taken together, our observations raise the possibility that Nef triggers the endocytosis of a novel antiviral factor that is active against both laboratory-adapted and primary HIV-1 strains. IMPORTANCE The Nef protein of HIV-1 and the unrelated glycoGag protein of a murine leukemia virus similarly prevent the uptake of antiviral host proteins called SERINC3 and SERINC5 into HIV-1 particles, which enhances their infectiousness. We now show that although both SERINC antagonists can in principle similarly enhance HIV-1 replication, glycoGag is unable to substitute for Nef in primary human cells and in a T cell line called MOLT-3. In MOLT-3 cells, Nef remained crucial for HIV-1 replication even in the absence of SERINC3 and SERINC5. The pronounced effect of Nef on HIV-1 spreading in MOLT-3 cells correlated with the ability of Nef to engage cellular endocytic machinery and to downregulate the HIV-1 receptor CD4 but nevertheless persisted in the absence of CD4 downregulation. Collectively, our results provide evidence for a potent novel restriction activity that affects even relatively SERINC-resistant HIV-1 isolates and is counteracted by Nef.
format article
author Yuanfei Wu
Balaji Olety
Eric R. Weiss
Elena Popova
Hikaru Yamanaka
Heinrich Göttlinger
author_facet Yuanfei Wu
Balaji Olety
Eric R. Weiss
Elena Popova
Hikaru Yamanaka
Heinrich Göttlinger
author_sort Yuanfei Wu
title Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5
title_short Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5
title_full Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5
title_fullStr Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5
title_full_unstemmed Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5
title_sort potent enhancement of hiv-1 replication by nef in the absence of serinc3 and serinc5
publisher American Society for Microbiology
publishDate 2019
url https://doaj.org/article/4570759b8a0d412fab429d4bc1dbaa0d
work_keys_str_mv AT yuanfeiwu potentenhancementofhiv1replicationbynefintheabsenceofserinc3andserinc5
AT balajiolety potentenhancementofhiv1replicationbynefintheabsenceofserinc3andserinc5
AT ericrweiss potentenhancementofhiv1replicationbynefintheabsenceofserinc3andserinc5
AT elenapopova potentenhancementofhiv1replicationbynefintheabsenceofserinc3andserinc5
AT hikaruyamanaka potentenhancementofhiv1replicationbynefintheabsenceofserinc3andserinc5
AT heinrichgottlinger potentenhancementofhiv1replicationbynefintheabsenceofserinc3andserinc5
_version_ 1718427210807771136